Donald Major - Precision Optics, Consultant
| POCI Stock | 5.03 0.29 5.45% |
Insider
Donald Major is Consultant of Precision Optics,
| Age | 63 |
| Address | 22 East Broadway, Gardner, MA, United States, 01440 |
| Phone | 978 630 1800 |
| Web | https://www.poci.com |
Precision Optics, Management Efficiency
The company has return on total asset (ROA) of (0.0929) % which means that it has lost $0.0929 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2669) %, meaning that it created substantial loss on money invested by shareholders. Precision Optics,'s management efficiency ratios could be used to measure how well Precision Optics, manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.4. The current Return On Capital Employed is estimated to decrease to -0.24. As of now, Precision Optics,'s Intangible Assets are increasing as compared to previous years. The Precision Optics,'s current Intangibles To Total Assets is estimated to increase to 0.57, while Total Current Assets are projected to decrease to under 3.6 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Stefano Grassi | Essilor International SA | 50 | |
| Fredrik Widman | Intuitive Surgical | N/A | |
| Ariel Bauer | EssilorLuxottica Socit anonyme | N/A | |
| Alka FACMG | Bionano Genomics | 51 | |
| MS MBA | Bionano Genomics | N/A | |
| Keisha Harcum | Milestone Scientific | N/A | |
| Ellen Bjurgert | Coloplast A | N/A | |
| John III | Retractable Technologies | 55 | |
| Mark Oldakowski | Bionano Genomics | 50 | |
| Ariel Bauer | Essilor International SA | N/A | |
| Aurelio Sahagun | Straumann Holding AG | 50 | |
| KokKien Loh | Straumann Holding AG | 56 | |
| Mark CPA | Bionano Genomics | N/A | |
| Dov Elefant | Femasys | 57 | |
| Dorthe Ronnau | Coloplast A | 57 | |
| Dennis Kaysen | Coloplast A | N/A | |
| Francesco Milleri | Essilor International SA | 64 | |
| Robert MBA | Bionano Genomics | 56 | |
| Dennis Kaysen | Coloplast AS | N/A | |
| Donna Polizio | Bionano Genomics | N/A | |
| Rahma Samow | Straumann Holding AG | 44 | |
Management Performance
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.0929 |
Precision Optics, Leadership Team
Elected by the shareholders, the Precision Optics,'s board of directors comprises two types of representatives: Precision Optics, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Precision. The board's role is to monitor Precision Optics,'s management team and ensure that shareholders' interests are well served. Precision Optics,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Precision Optics,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephanie Hansen, Director Resources | ||
| Daniel Habhegger, CFO Sec | ||
| Donald Major, Consultant | ||
| Divaker Mangadu, President Division | ||
| John Hargraves, Director Operations | ||
| Jeffrey DiRubio, Executive Marketing | ||
| Richard Forkey, Advisor Founder | ||
| Bruce Radl, Director Development | ||
| Joseph Forkey, President, CEO | ||
| Richard Cyr, Optics Mang | ||
| Clay Schwabe, Vice Marketing | ||
| Wayne Coll, CFO Secretary | ||
| Mahesh Lawande, Chief Officer |
Precision Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Precision Optics, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.0929 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.29) % | ||||
| Current Valuation | 34.04 M | ||||
| Shares Outstanding | 6.35 M | ||||
| Shares Owned By Insiders | 24.86 % | ||||
| Shares Owned By Institutions | 32.15 % | ||||
| Number Of Shares Shorted | 6.04 K | ||||
| Price To Book | 3.15 X |
Currently Active Assets on Macroaxis
When determining whether Precision Optics, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precision Optics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precision Optics, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precision Optics, Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precision Optics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more detail on how to invest in Precision Stock please use our How to Invest in Precision Optics, guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision Optics,. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision Optics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 3.148 | Quarterly Revenue Growth (0.06) | Return On Assets (0.09) | Return On Equity (0.27) |
The market value of Precision Optics, is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision Optics,'s value that differs from its market value or its book value, called intrinsic value, which is Precision Optics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision Optics,'s market value can be influenced by many factors that don't directly affect Precision Optics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision Optics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision Optics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision Optics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.